Letters to the Editor
Vol. 16 No. 1 (2024): Review Articles, Original Article, Scientific Letter, Case Reports Letter to the Editor
https://doi.org/10.4084/MJHID.2024.025

Successful treatment of de novo acute myeloid leukaemia associated aortitis by induction chemotherapy alone

Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
Published: February 29, 2024
616
Views
990
Downloads
84
HTML
Acute Myeloid Leukemia, AML, Aortitis, Panaortitis, vasculitis, large vessel vasculitis, Inflammatory diseases, systemic inflammatory or autoimmune diseases, Paraneoplastic, Induction chemotherapy, intensive chemotherapy

Authors

Urbain Tauveron--Jalenques
urbain.tauveron--jalenques@etu.uca.fr
a:1:{s:5:"en_US";s:20:"CHU Clermont-Ferrand";}, France.
Vincent Grobost
Internal Medicine Department, Clermont-Ferrand University Hospital, Clermont Ferrand, France, France.
Benoît Magnin
Department of Radiology, Clermont-Ferrand University Hospital, Clermont Ferrand, France, France.
Cécile Moluçon-Chabrot
Cellular Therapy and Clinical Haematology Departement, Clermont-Ferrand University Hospital, Clermont Ferrand, France, France.
Jacques-Olivier Bay
Cellular Therapy and Clinical Haematology Departement, Clermont-Ferrand University Hospital, Clermont Ferrand, France and EA7453 (CHELTER), Clermont Auvergne University, Clermont-Ferrand, France, France.
Olivier Tournilhac
Cellular Therapy and Clinical Haematology Departement, Clermont-Ferrand University Hospital, Clermont Ferrand, France and EA7453 (CHELTER), Clermont Auvergne University, Clermont-Ferrand, France, France.
Romain Guièze
Cellular Therapy and Clinical Haematology Departement, Clermont-Ferrand University Hospital, Clermont Ferrand, France and EA7453 (CHELTER), Clermont Auvergne University, Clermont-Ferrand, France, France.

Downloads

Download data is not yet available.

Citations

Crossref
Scopus
Google Scholar
Europe PMC
Roupie AL, de Boysson H, Thietart S et al. Giant-cell arteritis associated with myelodysplastic syndrome: French multicenter case control study and literature review. Autoimmun Rev. 2020 Feb;19(2):102446.
Attias D, Laor R, Zuckermann E et al. Acute neutrophilic myositis in Sweet's syndrome: late phase transformation into fibrosing myositis and panniculitis. Hum Pathol. 1995 Jun;26(6):687-90.
Haidar NA, Ayvazian HJ, Farhat F. AML-214: case report: A rare case presentation and detection of acute promyelocytic leukemia. Clinical Lymphoma, Myeloma and Leukemia. 2021;S292.
Ireifej B, Freijat M, Song D et al. Aortitis presenting as acute myeloid leukemia - A case report. Ann Med Surg (Lond). 2022 Jul 31;80:104255.
Kouroukli O, Symeonidis A, Foukas P et al. Bone Marrow Immune Microenvironment in Myelodysplastic Syndromes. Cancers (Basel). 2022 Nov 17;14(22):5656.
Mekinian A, Grignano E, Braun T et al. Systemic inflammatory and autoimmune manifestations associated with myelodysplastic syndromes and chronic myelomonocytic leukaemia: a French multicentre retrospective study. Rheumatology (Oxford). 2016 Feb;55(2):291-300.
Roupie AL, Guedon A, Terrier B et al. Vasculitis associated with myelodysplastic syndrome and chronic myelomonocytic leukemia: French multicenter case-control study. Semin Arthritis Rheum. 2020 Oct;50(5):879-884.

Ethics Approval

Case Report, acute myeloid leukemia, immunology

How to Cite



“Successful treatment of de novo acute myeloid leukaemia associated aortitis by induction chemotherapy alone” (2024) Mediterranean Journal of Hematology and Infectious Diseases, 16(1), p. e2024025. doi:10.4084/MJHID.2024.025.
Copyright (c) 2024 Urbain Tauveron--Jalenques, Vincent Grobost, Benoît Magnin, Cécile Moluçon-Chabrot, Jacques-Olivier Bay, Olivier Tournilhac; Romain Guièze Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.